This protocol is judged by an institutional critique board, an unbiased team that reviews any medical trials involving people. If a study requires a Program I drug, after the board approves the protocol as ethical, the researchers have to apply for an investigational new drug (IND) number with the FDA.Use of unlawful medication is “staggering”